Clinical trials: Polyneuropathy Associated With Anti-MAG Antibodies (Anti-MAG Polyneuropathy)
Charcot-Marie-Tooth, CMT1A
Studying Nerve Function and Structure in Charcot-Marie-Tooth Disease, Anti-MAG Neuropathy and CIDP
The project aims to perform both conventional nerve-conduction studies and axonal-excitability assessments using the TRONDF protocol in patients with selected forms of Charcot-Marie-Tooth disease, with comparison to individuals…
- Conditions
- Charcot-Marie-Tooth, CMT1A, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Polyneuropathy Associated With Anti-MAG Antibodies (Anti-MAG Polyneuropathy)
- Trial name
- CMT-NFS (NCT07461896)
- Where
- Italy
- Volunteers
- 39 people
- Sponsor
- Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Anti-MAG IgM-associated Demyelinating Polyneuropathy
Zanubritnib and Anti-MAG Neuropathy
The MAZINGA study is a multicenter, open-label, single-arm Phase IIA clinical trial designed to evaluate the efficacy, safety, and tolerability of zanubrutinib in patients with IgM anti-myelin-associated glycoprotein (anti-MAG)…
- Trial name
- MAZINGA (NCT07392229)
- Testing
- Zanubrutinib Oral Capsule
- Where
- 7 sites in Italy
- Volunteers
- 50 people
- Sponsor
- Azienda Ospedaliera di Padova